Lundbeck to buy Parkinson’s drug developer in potential…

Lundbeck to buy Parkinson’s drug developer in potential…
COPENHAGEN, March 16 (Reuters) - Danish drugmaker Lundbeck said on Friday it had agreed to buy Prexton Therapeutics, which has drug candidate foliglurax in ... read more
Source: Daily MirrorPublished on 2018-03-16